Deals & Corporate Governance
- 
									February 13, 2025
									Mallinckrodt Fails To Halt Airgas' Generic Nitric Oxide DrugA Delaware federal judge has rejected Mallinckrodt Pharmaceuticals' attempt to block French industrial gas company Airgas Healthcare from selling a generic version of its inhaled nitric oxide treatment, saying Mallinckrodt didn't show enough evidence that Airgas infringed its patents or that it would suffer irreparable harm. 
- 
									February 13, 2025
									Paul Hastings, Cooley Lead Obesity-Focused Aardvark's IPOObesity-focused Aardvark Therapeutics Inc. began trading Thursday after pricing a $94 million initial public offering at the bottom of its range, represented by Paul Hastings LLP and underwriters' counsel Cooley LLP, joining a string of biotechnology firms to go public recently. 
- 
									February 12, 2025
									Bausch Health Beats Suit Over 'Faking' Financial StabilityPharmaceutical company Bausch Health Cos. Inc. and its top brass have beaten, for now, a proposed class action accusing them of misleading shareholders about threats to the company's financial stability, with a New Jersey federal judge finding Wednesday that most of the challenged statements in the complaint are inactionable. 
- 
									February 12, 2025
									Supply Co. Files Failsafe $387M Suit Amid Threat Of DismissalA medical supply procurement company has re-upped claims that a pharmaceutical middleman cut it out of a billion-dollar deal with the U.K. government to sell COVID-19 tests after newly unveiled information threatened to derail the long-running litigation. 
- 
									February 11, 2025
									Takeaways From This Week's Healthcare EarningsA host of pharmaceutical companies posted earnings this past week, with executives touching on near term growth plans and potential cost-cutting measures on calls with investors. 
- 
									February 11, 2025
									Research Org Faces Investor Suit Over Customer Cost-CuttingClinical research organization Icon PLC has been hit with a proposed shareholder class action in New York federal court, alleging it misled investors about a slowdown in demand the company experienced due to customers implementing drastic cost-reduction measures that involved research and development expenditures. 
- 
									February 11, 2025
									Fla. Judge OKs $7M Deal In Health Data Breach Class ActionA Florida federal judge Tuesday granted final approval of a $7 million class action settlement as part of multidistrict litigation over the theft of personal information from millions of U.S. citizens in a health data breach linked to a Russian ransomware group. 
- 
									February 11, 2025
									Novartis To Buy US Pharma Biz Anthos For Up To $3.1BNovartis AG said Tuesday that it plans to buy Anthos Therapeutics Inc. for up to $3.1 billion, allowing the Swiss pharmaceutical heavyweight to return a drug that originated at the company back into its portfolio of cardiovascular therapies. 
- 
									February 10, 2025
									Pharma Co. Misled Investors On Depression Drug, Suit SaysBrain disease drugmaker Neumora Therapeutics Inc. has been hit with a proposed shareholder class action alleging that the company and its initial public offering underwriters failed to disclose prior to the $250 million IPO that Neumora's clinical trial for a depression treatment was very unlikely to yield promising results. 
- 
									February 10, 2025
									UnitedHealth Says Fed Suit Imperils Deal's Many BenefitsUnitedHealth Group and home health and hospice giant Amedisys Inc. responded to the U.S. Department of Justice's merger challenge Friday by telling a Maryland federal judge that the government is taking quotes out of context, focusing on "artificially narrow geographic markets" and misjudging market realities. 
- 
									February 07, 2025
									Taxation With Representation: Kirkland, Latham, SkaddenIn this week's Taxation With Representation, Triumph Group goes private via Berkshire Partners and Warburg Pincus affiliates, alternative asset manager TPG buys Altus Power, Globus Medical buys Nevro Corp., and Honeywell separates its automation and aerospace technology businesses, resulting in the formation of three distinct companies. 
- 
									February 06, 2025
									Drug Cos. Urge Full Fed. Circ. To Hear Teva Orange Book RowThe branded pharmaceutical industry is lining up behind a legal effort from Israeli drugmaker Teva that wants the full Federal Circuit to hear a dispute over delisting patents from the U.S. Food and Drug Administration's Orange Book. 
- 
									February 06, 2025
									GSK's Zantac Woes Gave Investors Heartburn, Suit SaysThe maker of heartburn and acid reflux relief tablet Zantac has been hit with a shareholder suit in Pennsylvania federal court alleging that the company suffered stock price losses after it was revealed that for nearly 40 years the company knew that Zantac contained high levels of a cancer-causing compound. 
- 
									February 06, 2025
									Globus Medical Buys Device-Maker Nevro In $250M DealMusculoskeletal solutions company Globus Medical, advised by Wyrick Robbins Yates & Ponton LLP, on Thursday announced plans to buy Latham & Watkins LLP-led medical device company Nevro Corp. in an all-cash deal with an equity value of roughly $250 million. 
- 
									February 06, 2025
									Arnall Golden Hires Home Care & Hospice CEO In DCArnall Golden Gregory LLP has hired the former head of the National Association for Home Care & Hospice, to join its Washington, D.C., office after nearly 40 years with the organization, the firm announced Tuesday. 
- 
									February 05, 2025
									Wachtell, Skadden Guide Becton's Bid To Sell Diagnostics BizBecton Dickinson and Co. has agreed to divest its biosciences and diagnostics unit in order to focus more resources on medical technology and maximize shareholder value, the company said on Wednesday. 
- 
									February 05, 2025
									Proskauer Fights Another DQ Bid In NJ Hospital Antitrust SuitA New Jersey federal magistrate judge was right to allow Proskauer Rose LLP to continue as counsel for RWJBarnabas Health Inc. since the firm's prior advice to CarePoint Health on its use of COVID-19 relief funds is unrelated to the antitrust lawsuit currently playing out between the two companies, according to the firm. 
- 
									February 05, 2025
									Activist Nominates 4 Director Candidates To Kenvue BoardActivist investor Starboard Value LP on Wednesday unveiled its slate of four director candidates to be nominated to consumer products company Kenvue Inc.'s board of directors, saying that significant changes to the board are necessary to ensure the company is managed and overseen in a manner consistent with the best interests of its shareholders. 
- 
									February 04, 2025
									McKesson, Others Beat Indirect Drug Reseller Price-Fix SuitA Pennsylvania federal judge permanently tossed antitrust claims from indirect generic-drug resellers who alleged distributors like McKesson Corp. and AmerisourceBergen colluded with manufacturers to fix prices of many medications, writing Monday the plaintiffs fail to show the existence of such an agreement between drugmakers and distributors. 
- 
									February 04, 2025
									Fed. Circ. Grapples With Extensions On Reissued PatentsThe Federal Circuit is set to decide when a reissued patent actually expires after fielding arguments Tuesday morning from Merck and the generic-drug makers who are trying to break the pharmaceutical giant's hold on a blockbuster drug that counteracts the effects of anesthesia. 
- 
									February 04, 2025
									McKesson Paying $850M For Top Stake In Eye Health Co.Irving, Texas, healthcare services company McKesson Corp. said Tuesday it had agreed to buy a controlling interest in PRISM Vision, an ophthalmology services provider, from private equity firm Quad-C for $850 million. 
- 
									February 04, 2025
									Biotechs Line Up Backups Amid UncertaintyIn an uncertain environment, biotech companies are pursuing multiple opportunities at the same time, leaning into an old but increasingly popular strategy that gives them leverage and options when striking deals. 
- 
									February 04, 2025
									Healthcare REIT Closes $159M Life Sciences Campus SaleDiversified Healthcare Trust sold off a three-building life sciences campus in San Diego for $159 million as the healthcare-focused REIT looks to pay down debt. 
- 
									February 03, 2025
									Calif. OTA Denies Sales Tax Refund For Drug System PartsA biopharmaceutical company is not eligible for refunds of sales and use taxes for components of a diabetes drug delivery system that it developed but was never federally approved, the California Office of Tax Appeals said in a ruling released Monday. 
- 
									January 31, 2025
									Pharmacy Escapes Novo Nordisk's Suit Over OzempicA Florida federal judge has tossed a lawsuit by Novo Nordisk trying to stop a compounding pharmacy from dispensing drugs with the same active ingredient as Nordisk weight loss and diabetes drugs, finding that the drugmaker's claims are preempted by federal law. 
Expert Analysis
- 
								
								Recent Provider Relief Fund Audits Are Just The Beginning  Though the Health Resources and Services Administration's initial audits of the Provider Relief Fund program appear to be limited in scope, fund recipients should prepare for additional oversight, scrutiny and disallowances as the HRSA ramps up its efforts, say Brian Lee and Christopher Frisina at Alston & Bird. 
- 
								
								5 Ways Firms Can Rethink Office Design In A Hybrid World  As workplaces across the country adapt to flexible work, law firms must prioritize individuality, amenities and technology in office design, says Kristin Cerutti at Nelson Worldwide. 
- 
								
								Bar Score Is Best Hiring Metric Post-Affirmative Action  After the U.S. Supreme Court's ruling striking down affirmative action admissions policies, law firms looking to foster diversity in hiring should view an applicant's Multistate Bar Examination score as the best metric of legal ability — over law school name or GPA, says attorney Alice Griffin. 
- 
								
								Joint Ventures Given More Edge In Set-Aside Contract Awards  The recent Court of Federal Claims decision in SH Synergy prompted the General Services Administration to remold proposal evaluation schemes to favor mentor-protégé joint ventures, a business structure that has taken over the world of set-aside governmentwide acquisition contracts, say Roger Abbott and Stephen Ramaley at Miles & Stockbridge. 
- 
								
								New Health Data Compliance Considerations For Pa. Lawyers  Given the regularity with which attorneys handle private health information, it is important for Pennsylvania firms to understand recent significant amendments to the state's data breach law, which address information not currently covered by federal law, says Mark Mattioli at Post & Schell. 
- 
								
								Ghosting In BigLaw: How To Come Back From Lack Of Feedback  Junior associates can feel powerless when senior colleagues cut off contact instead of providing useful feedback, but young attorneys can get back on track by focusing on practical professional development and reexamining their career priorities, says Rachel Patterson at Orrick. 
- 
								
								Conn. Certificate-Of-Need Law Will Bring Greater Efficiency  A new Connecticut law benefits health care organizations by establishing more concrete deadlines and requirements for the state's certificate-of-need law enforcer, and allows the enforcement agency to carry out its duties more efficiently, say attorneys at Robinson & Cole. 
- 
								
								Steps To Success For Senior AssociatesExcerpt from Practical Guidance  Adriana Paris at Rissman Barrett discusses the increased responsibilities and opportunities that becoming a senior associate brings and what attorneys in this role should prioritize to flourish in this stressful but rewarding next level in their careers. 
- 
								
								Legal Profession Must Do More For Lawyers With Disabilities.jpg)  At the start of Disability Pride month, Rosalyn Richter at Arnold & Porter looks at why lawyers with disabilities are significantly underrepresented in private practice, asserting that law firms and other employers must do more to conquer the implicit bias that deters attorneys from seeking accommodations. 
- 
								
								Scope Of FTC's Health Info Enforcement May Expand  The Federal Trade Commission's proposed amendments to the Health Breach Notification Rule signal the agency's mounting efforts to regulate consumer health information beyond the reaches of the Health Information Portability and Accountability Act, which does not cover many recent health apps and technologies, say Jodi Daniel and Brandon Ge at Crowell & Moring. 
- 
								
								Appellate Funding Disclosure: No Mandate Is Right Choice.jpg)  The Advisory Committee on Appellate Rules' recent decision, forgoing a mandatory disclosure rule for litigation funding in federal appeals, is prudent, as third-party funding is only involved in a minuscule number of federal cases, and courts have ample authority to obtain funding information if necessary, says Stewart Ackerly at Statera Capital. 
- 
								
								How NY Law Affects Scrutiny Of Health Care PE Transactions.jpg)  A recently passed New York law will strengthen pretransanction notification requirements for health care entities — particularly those backed by private equity — but contains several ambiguities that will hopefully be clarified before the law takes effect in August, say attorneys at Norton Rose. 
- 
								
								How Attys Can Avoid Exposing Their Firms To Cyberattacks  Attorneys are the weakest link in their firms' cyberdefenses because hackers often exploit the gap between individuals’ work and personal cybersecurity habits, but there are some steps lawyers can take to reduce the risks they create for their employers, say Mark Hurley and Carmine Cicalese at Digital Privacy & Protection.